Clinical Trial Update: A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 study completed evaluating the immunogenicity of a swine-origin A/H1N1 influenza vaccine in healthy adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Swine-origin Influenza

Drugs mentioned

• Panenza (Influenza vaccine, swine-origin A/H1N1)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Influenza, Swine-origin A/H1N1 Influenza | Phase 2 | Status: COMPLETED